ZTEK
HealthcareZentek Ltd.
$0.73
+$0.06 (+8.96%)
Jan 5, 2026
Price History (1Y)
Analysis
Zentek Ltd. is a healthcare company operating in the medical instruments and supplies industry. The company has a market capitalization of $78.23M, indicating a relatively small scale compared to larger industry players. With 25 employees, Zentek maintains a lean workforce, which may be attributed to its sector and industry. Zentek's financial health is challenging, with significant losses on the bottom line. The company reported net income of -$8,194,978 over the trailing twelve months, accompanied by an EBITDA loss of $-8,240,483. Additionally, the operating margin stands at -36,955.2%, and the profit margin is 0.0%. Returns on equity and assets are also negative, at -54.2% and -28.1%, respectively. The company's debt-to-equity ratio is 16.16, indicating a relatively high level of indebtedness compared to shareholder equity. Cash levels stand at $1.33M, while debt totals $1.89M. Zentek's valuation metrics are not favorable. With a price-to-book ratio of 9.03 and a price-to-sales ratio of 85.46, the company appears overvalued relative to its peers. The EV/EBITDA multiple is -8.82, suggesting significant concerns about earnings prospects. Revenue growth has been negative over the past year, at -60.5%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Zentek Ltd.
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coatings under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It also developing aptamers and rapid detection; and graphene oxide synthesis and graphene synthesis products. In addition, the company owns a 100% interest in the Albany graphite project located in Northern Ontario, Canada. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.
Visit website →Key Statistics
- Market Cap
- $78.23M
- P/E Ratio
- N/A
- 52-Week High
- $1.84
- 52-Week Low
- $0.62
- Avg Volume
- 66.50K
- Beta
- 0.43
Company Info
- Industry
- Medical Instruments & Supplies
- Exchange
- NCM
- Country
- Canada
- Employees
- 25